Table 4 Comparison of comorbidity data between normal human liver and ALD cohort
Normal human liver ( n = 17) | ALD (cirrhosis) ( n = 10) | Statistical significance | |
|---|---|---|---|
Hypertension (N, %) | 4 (23.5%) | 4 (40%) | ns |
Any hypertensive medication (N, %) | 4 (23.5%) | 0 (0%) | P = 0.046 |
T2DM (N, %) | 0 (0%) | 0 (0%) | ns |
Diet treated | 0 (0%) | 0 (0%) | ns |
Cardiovascular disease (N, %) | 2 (11.7%) | 0 (0%) | ns |
Dyslipidemia treated with lipid lowering agents (N, %) | 3 (17.6%) | 0 (0%) | ns |
1 Med | 3 (17.6%) | 0 (0%) | ns |
>2 Meds | 0 (0%) | 0 (0%) | ns |